Table 7. Multivariate analysis of progression-free survival of 40 newly diagnosed NSCLC patients.
| Parameter | HR (95%CI) | P |
|---|---|---|
| Treg | ||
| <3.6 | 1 | 0.010 |
| ≥3.6 | 3.76(1.38-10.22) | |
| Differentiation | ||
| Well/moderate | 1 | 0.152 |
| Poor | 2.46(0.72-8.40) | |
| AJCC stage | ||
| 1-3 | 1 | 0.005 |
| 4 | 5.74(1.71-19.19) | |
| Nodal stage | ||
| N0 | 1 | 0.004 |
| N1-N3 | 8.12(1.94-33.98) | |
| ECOG PS | ||
| 0 | 1 | 0.101 |
| 1-2 | 2.10(0.65-6.75) | |
Abbreviations: NSCLC: non-small cell lung cancer; HR: hazard ratio; ECOG PS: Eastern Cooperative Oncology Group performance status; Treg: regulatory T cells; AJCC: American Joint Committee on Cancer.